UCL Faculty of Medical Sciences


VIRTUAL EVENT: Harnessing lung cancer evolution for clinical benefit

31 January 2023, 5:00 pm–6:00 pm

A photo of Mariam Jamal-Hanjani accompanied by an image of cancer cells

Join us to find out more about the process of lung cancer evolution and how to better treat it.

This event is free.

Event Information

Open to







Kate Thomas & Dr Nephtali Marina-Gonzalez – Faculty of Medical Sciences

Lung cancers are genetically very diverse in character and their genomic landscape can evolve from early to late stage disease. Understanding the process of lung cancer evolution can help identify cancers with more aggressive biology and identify novel ways in which we can track evolution of the disease and potentially treat it.

This lecture will be followed by a Q&A with our speaker, Dr Mariam Jamal-Hanjani.

Follow the conversation on Twitter: #FMSLectures

Access profile

This event will take place on Zoom Webinar.

A link to the event will be sent to you prior to the event start time.

Live captioning is available for this event.

We aim to make our events as inclusive as possible, so if you have any accessibility requirements or enquiries that are not covered in the above access profile please contact the events team at fmscomms@ucl.ac.uk. If you could contact us allowing as much time as possible before the event we will be able to ensure where required that the appropriate measures are taken.

About the Speaker

Mariam Jamal-Hanjani

Honorary Consultant at UCL Cancer Institute

A photo of Mariam Jamal-Hanjani

Mariam Jamal-Hanjani obtained her degrees in Physics and Medicine at UCL after which she completed her general medical and oncology training in London. In 2012, she was awarded a CRUK Clinical Research Fellowship to complete her PhD studies in chromosomal instability and intratumour heterogeneity with Charles Swanton for which she was awarded the McElwain and the Sylvia Lawler Scientific Prizes. In 2016, Mariam was awarded an NIHR Clinical Lectureship during which she established the UK-wide PEACE research autopsy programme which she co-leads with Charles Swanton. In 2018, she was appointed as Senior Clinical Lecturer and Honorary Consultant in Translational Lung Oncology in the CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, and in 2021 she was awarded a CRUK Career Establishment Award to study the biological processes driving metastatic disease and death in lung cancer. She is Principal Investigator of the national TRACERx lung study, Chief Investigator of the national PEACE study and Chief Scientific Investigator of the first-in-human CHIRON study investigating the clinical activity of autologous clonal neoantigen T cells in patients with advanced non-small cell lung cancer.